查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1757713

全球血管內動脈瘤修復市場

Endovascular Aneurysm Repair
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 276 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球血管內動脈瘤修復市場規模將達到 30 億美元

全球血管內動脈瘤修復市場規模預計在2024年為25億美元，預計到2030年將達到30億美元，在分析期間（2024-2030年）的複合年成長率為3.3%。腹部主動脈血管瘤是本報告分析的細分市場之一，預計其複合年成長率為3.0%，到分析期結束時將達到16億美元。胸主動脈瘤細分市場在分析期間的複合年成長率估計為3.9%。

美國市場規模估計為 6.776 億美元，中國市場預計複合年成長率為 6.1%

預計2024年美國血管內動脈瘤修復市場規模將達6.776億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到5.968億美元，在2024-2030年的分析期間內，複合年成長率為6.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為1.3%和2.5%。在歐洲，預計德國市場的複合年成長率為1.9%。

全球血管內動脈瘤修復市場—主要趨勢與促進因素摘要

為什麼血管內動脈瘤修復正在重新定義血管醫學中的動脈瘤治療？

血管內動脈瘤修復 (EVAR) 為腹主動脈瘤和胸主動脈瘤的治療帶來了革命性的變化，它是一種可取代傳統開放性手術的微創修復方法。該手術包括透過腹股溝的小切口插入血管支架，並透過鼠蹊部動脈將其引導至血管支架部位，在那裡部署以加強薄弱的血管壁並防止破裂。與開放性手術相比，EVAR 具有許多優勢，包括失血量更少、手術全期併發症更少、住院時間更短以及恢復時間更快。這對於老年患者和患有併發症而無法耐受大手術的患者尤其有利。由於人口老化、高血壓、吸菸、動脈粥狀硬化等原因，全球主動脈瘤發生率不斷上升，大大增加了對 EVAR 等更安全、更有效干預措施的臨床需求。隨著血管影像和血管支架設計的不斷改進，EVAR 已成為許多具有適當解剖結構的患者的首選治療方法。此外，廣泛的篩檢項目和影像技術的進步使得無症狀性動脈瘤的早期發現成為可能，從而擴大了EVAR的潛在治療範圍。因此，EVAR不僅改變了動脈瘤的治療方式，也透過提供一條低風險、高回報的復健和長壽之路，重塑了患者的期望。

技術進步如何提高 EVAR 手術的準確性和結果？

在血管支架設計、影像技術和手術的不斷創新的推動下，血管內動脈瘤修復領域正在迅速發展。現代血管支架設計靈活、耐用且貼合性好，可適應各種患者解剖結構，包括曲折和有角的血管。柵欄式和分叉式血管支架血管支架的應用使得能夠治療涉及或靠近主要動脈分支（如腎動脈和髂動脈）的動脈瘤，而這些病例先前被認為不適合 EVAR。即時 3D 影像引導導航系統，如融合成像和血管內超音波(IVUS)，已顯著提高移植物放置的準確性，並減少了併發症和顯影劑的需求。機器人輔助和導管輸送系統提高了精確度和操作員控制，尤其是在複雜的主動脈解剖結構中。人們也正在研究生物可吸收材料和藥物釋放型支架的創新，以改善移植物整合並降低長期風險，如內漏和移植物移位。術後監測也受益於穿戴式技術和行動醫療平台的進步，這些技術和平台實現了遠端追蹤和併發症的早期發現。這些技術創新不僅提高了EVAR手術的安全性和有效性，也擴大了其應用範圍，突破了血管內治療的極限。

為什麼 EVAR 的需求在各個人口群體和全球各個地區都在擴大？

由於臨床、經濟和人口統計等多種因素，不同年齡層、不同患者群體和不同地理區域對血管內動脈瘤修復的需求正在迅速成長。在高所得國家，人口老化是主要促進因素，男性，尤其是65歲及以上男性，患有腹部主動脈血管瘤(AAA) 的風險更高。這些國家也受惠於完善的篩檢計畫、先進的影像技術以及專科血管中心的便利，從而能夠在動脈瘤破裂前進行早期診斷和選擇性血管內修復 (EVAR)。相較之下，新興國家的糖尿病、高血壓和吸菸等心血管危險因子急劇上升，加重了動脈瘤的負擔。隨著醫療基礎設施的改善和血管內治療可近性的提高，這些市場為EVAR技術帶來了巨大的成長機會。此外，在培訓、流程標準化和血管支架系統簡化的推動下，EVAR的應用範圍正在從三級醫療中心擴展到區域和社區醫院。患者在治療決策中也發揮更積極的作用，其中許多人更傾向於創傷性更小、恢復更快、術後疼痛更少的治療方案。 EVAR 的仿單標示外使用已在患有結締組織疾病和創傷性主動脈損傷的年輕患者中得到探索，並取得了令人欣喜的成果。從軍事醫學到災難應變和移動外科手術單元，EVAR 的多功能性使其適用於各種醫療保健環境，進一步推動了全球需求。

推動血管內動脈瘤修復市場加速成長的因素是什麼？

血管內動脈瘤修復市場的成長受到技術、臨床、經濟和監管等多種因素的共同驅動，這些因素共同推動著該產業的擴張和成熟。最重要的成長要素之一是主動脈瘤盛行率的不斷上升，尤其是在老化人口和具有心血管風險因素的人群中。越來越多的醫療保健提供者選擇血管內動脈瘤修復 (EVAR) 而非開放性手術，因為其併發症率更低、恢復時間更短且對醫院資源的利用率更低。監管核准和報銷政策也發揮關鍵作用，越來越多的 EVAR 設備被批准用於更廣泛的解剖適應症，並被納入保險覆蓋範圍。門診血管外科中心和混合手術室的興起，使得醫院無需大規模基礎設施建設即可實施 EVAR。此外，醫生和患者對動脈瘤症狀、風險因素和篩檢建議的認知不斷提高，也推動了早期診斷和及時介入。醫療設備製造商正在大力投資研發下一代移植物和輸送系統，建構一系列有望減少手術併發症和長期併發症的創新技術。隨著臨床指南持續青睞微創解決方案，以及全球醫療保健系統轉向預防性護理，EVAR 預計將在成熟市場和新興市場保持持續的高成長動能。

部分

適應症（腹部主動脈血管瘤、胸主動脈瘤、其他適應症）；產品（經皮EVAR、柵欄式 EVAR、主動脈支架和 TAA 移植物、其他產品）

受訪公司範例（總合36家）

  • Abbott Laboratories
  • Bolton Medical, Inc.
  • Boston Scientific Corporation
  • CR Bard（a BD company）
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Cordis Corporation（Johnson & Johnson）
  • Endologix, Inc.
  • Endospan Ltd.
  • Getinge AB
  • JOTEC GmbH
  • L. Gore & Associates, Inc.（Gore Medical）
  • Lombard Medical Limited
  • Medtronic plc
  • Philips Healthcare
  • Shanghai MicroPort Medical（Group）Co., Ltd.
  • Teleflex Incorporated
  • Terumo Corporation
  • TriVascular Technologies, Inc.
  • Volcano Corporation（a Philips company）

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP35014

Global Endovascular Aneurysm Repair Market to Reach US$3.0 Billion by 2030

The global market for Endovascular Aneurysm Repair estimated at US$2.5 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Abdominal Aortic Aneurysm, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Thoracic Aortic Aneurysm segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$677.6 Million While China is Forecast to Grow at 6.1% CAGR

The Endovascular Aneurysm Repair market in the U.S. is estimated at US$677.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$596.8 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Endovascular Aneurysm Repair Market - Key Trends & Drivers Summarized

Why Is Endovascular Aneurysm Repair Redefining Aneurysm Treatment in Vascular Medicine?

Endovascular Aneurysm Repair (EVAR) has revolutionized the management of abdominal and thoracic aortic aneurysms by providing a minimally invasive alternative to traditional open surgical repair. This technique involves inserting a stent graft through a small incision in the groin and navigating it via the femoral artery to the site of the aneurysm, where it is deployed to reinforce the weakened vessel wall and prevent rupture. EVAR offers numerous benefits over open surgery, including reduced blood loss, lower perioperative morbidity, shorter hospital stays, and faster recovery times. It is especially advantageous for elderly patients or those with comorbidities who may not tolerate major surgery. The rising global incidence of aortic aneurysms-driven by aging populations, hypertension, smoking, and atherosclerosis-has significantly increased the clinical need for safer, more efficient interventions like EVAR. As vascular imaging and stent-graft design continue to improve, EVAR has become the first-line treatment for many patients with suitable anatomy. Additionally, widespread screening programs and improved diagnostic imaging have led to earlier detection of asymptomatic aneurysms, expanding the potential candidate pool for EVAR procedures. As a result, EVAR is not only transforming how aneurysms are treated but also reshaping patient expectations by offering a lower-risk, high-reward path to recovery and longevity.

How Are Technological Innovations Enhancing the Precision and Outcomes of EVAR Procedures?

The field of endovascular aneurysm repair is advancing rapidly, fueled by continual innovations in stent graft design, imaging technologies, and procedural techniques. Modern stent grafts are now designed with greater flexibility, durability, and conformability to accommodate a wider range of patient anatomies, including those with tortuous or angulated vessels. The advent of fenestrated and branched stent grafts has made it possible to treat aneurysms that involve or are close to major arterial branches such as the renal and iliac arteries-cases that were previously deemed unsuitable for EVAR. Real-time 3D image-guided navigation systems, such as fusion imaging and intravascular ultrasound (IVUS), have dramatically improved the accuracy of graft placement, reducing complications and the need for contrast agents. Robotic-assisted and catheter-based delivery systems are enhancing precision and operator control, particularly in complex aortic anatomies. Innovations in bioresorbable materials and drug-eluting stents are also being explored to improve graft integration and reduce long-term risks such as endoleaks or graft migration. Post-procedural monitoring has benefited from advancements in wearable technology and mobile health platforms, which allow for remote follow-up and early detection of complications. Collectively, these innovations are not only improving the safety and efficacy of EVAR procedures but also expanding their applicability, pushing the boundaries of what can be achieved through endovascular intervention.

Why Is the Demand for EVAR Expanding Across Demographics and Global Regions?

The demand for endovascular aneurysm repair is expanding rapidly across age groups, patient profiles, and geographic regions due to a combination of clinical, economic, and demographic factors. In high-income countries, the aging population is a key driver, with men over 65 being particularly at risk for abdominal aortic aneurysms (AAA). These nations also benefit from established screening programs, advanced imaging capabilities, and access to specialized vascular centers, enabling early diagnosis and elective EVAR before rupture occurs. In contrast, emerging economies are seeing a surge in cardiovascular risk factors-including diabetes, hypertension, and smoking-contributing to a growing aneurysm burden. As healthcare infrastructure improves and access to endovascular procedures increases, these markets represent significant growth opportunities for EVAR technologies. Moreover, the adoption of EVAR is extending beyond tertiary care centers to regional and community hospitals, supported by advancements in training, procedural standardization, and simplified stent-graft systems. Patients are also playing a more active role in treatment decisions, with many favoring minimally invasive options that allow for quicker recovery and less postoperative pain. In younger patients with connective tissue disorders or traumatic aortic injuries, off-label use of EVAR is being explored with promising outcomes. From military medicine to disaster response and mobile surgical units, the versatility of EVAR makes it highly adaptable across diverse healthcare environments, further driving global demand.

What Factors Are Fueling the Accelerated Growth of the Endovascular Aneurysm Repair Market?

The growth in the endovascular aneurysm repair market is driven by a convergence of technological, clinical, economic, and regulatory factors that collectively point to an expanding and maturing field. One of the most significant growth drivers is the increasing prevalence of aortic aneurysms, particularly in aging populations and among individuals with cardiovascular risk factors. Healthcare providers are increasingly opting for EVAR over open surgery due to its lower complication rates, shorter recovery time, and reduced hospital resource utilization-factors that align well with value-based healthcare models and cost-containment initiatives. Regulatory approvals and reimbursement policies are also playing a crucial role, with more EVAR devices receiving clearance for broader anatomical indications and being included in insurance coverage plans. The rise of outpatient vascular surgery centers and hybrid operating rooms has made it more feasible for hospitals to adopt EVAR without major infrastructure overhauls. Additionally, increased awareness among both physicians and patients regarding aneurysm symptoms, risk factors, and screening recommendations is driving earlier diagnosis and timely intervention. Medical device companies are investing heavily in R&D to develop next-generation grafts and delivery systems, creating a pipeline of innovations that promise to reduce procedural complexity and long-term complications. As clinical guidelines continue to favor minimally invasive solutions and global healthcare systems pivot toward proactive, preventative care, EVAR is poised for sustained, high-growth momentum across both mature and emerging markets.

SCOPE OF STUDY:

The report analyzes the Endovascular Aneurysm Repair market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Other Indications); Product (Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft, Other Products)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Bolton Medical, Inc.
  • Boston Scientific Corporation
  • C.R. Bard (a BD company)
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Cordis Corporation (Johnson & Johnson)
  • Endologix, Inc.
  • Endospan Ltd.
  • Getinge AB
  • JOTEC GmbH
  • L. Gore & Associates, Inc. (Gore Medical)
  • Lombard Medical Limited
  • Medtronic plc
  • Philips Healthcare
  • Shanghai MicroPort Medical (Group) Co., Ltd.
  • Teleflex Incorporated
  • Terumo Corporation
  • TriVascular Technologies, Inc.
  • Volcano Corporation (a Philips company)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Endovascular Aneurysm Repair - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Aging Patient Population Throws the Spotlight on Minimally Invasive Aneurysm Repair Options
    • Rising Prevalence of Abdominal Aortic Aneurysms Propels Growth in Endovascular Treatment Adoption
    • Preference for Shorter Hospital Stays Expands Addressable Market for EVAR Procedures
    • Innovation in Stent Graft Design Strengthens the Business Case for Complex Aneurysm Treatment
    • Advances in Imaging and Navigation Systems Accelerate Demand for Precision-Guided Repairs
    • Surge in Outpatient Vascular Procedures Sustains Growth in Ambulatory EVAR Solutions
    • Growing Surgeon Comfort with Endovascular Techniques Spurs Wider Adoption in Community Hospitals
    • Post-EVAR Monitoring Requirements Generate Opportunities for Device-Enabled Surveillance Systems
    • Rising Use of Custom and Fenestrated Grafts Expands Treatment in Anatomically Challenging Cases
    • Technology Convergence in Robotics and Endovascular Tools Enhances Precision and Outcomes
    • High-Risk Patient Demographics Create Market for EVAR as Preferred Alternative to Open Surgery
    • Global Expansion of Vascular Surgery Infrastructure Fuels EVAR Penetration in Emerging Regions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Endovascular Aneurysm Repair Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Endovascular Aneurysm Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Abdominal Aortic Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Abdominal Aortic Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Abdominal Aortic Aneurysm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Thoracic Aortic Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Thoracic Aortic Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Thoracic Aortic Aneurysm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Percutaneous EVAR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Percutaneous EVAR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Percutaneous EVAR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Fenestrated EVAR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Fenestrated EVAR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Fenestrated EVAR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Aortic Stents & TAA Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Aortic Stents & TAA Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Aortic Stents & TAA Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • JAPAN
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • CHINA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • EUROPE
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Endovascular Aneurysm Repair by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • FRANCE
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • GERMANY
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • INDIA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Endovascular Aneurysm Repair by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Endovascular Aneurysm Repair by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • AFRICA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030

IV. COMPETITION